Fosrenol and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosrenol (lanthanum carbonate) and Prograf (tacrolimus). Common drug interactions include skin oedema among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Fosrenol and Prograf. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Fosrenol?

Fosrenol has active ingredients of lanthanum carbonate. eHealthMe is studying from 5,922 Fosrenol users. Check the latest studies of Fosrenol.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

On Jul, 05, 2026

45 people who take Fosrenol and Prograf together, and have interactions are studied.

What are the common drug interactions of Fosrenol and Prograf, by gender? *:

female:

Skin oedema (swelling of skin)
Skin plaque (red, scaly patches to appear on the skin)
Vascular calcification (deposits of calcium in the blood vessels)
Anaemia (lack of blood)
Depression
Skin discolouration (change of skin colour)
Skin hypertrophy (skin cells enlarges)
Syncope (loss of consciousness with an inability to maintain postural tone)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Gingivitis (inflammation of gums)

male:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Drug level increased
Injury
Mobility decreased (ability to move is reduced)
Skin hypertrophy (skin cells enlarges)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
Gait disturbance
General physical health deterioration (weak health status)
Hypertension (high blood pressure)
Joint contracture (a permanent shortening of a muscle or joint)

What are the common drug interactions of Fosrenol and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
Humoral immune defect (impairment of humoral immunity)
Infection
Therapeutic response decreased (less preventive response)
Transplant rejection (a transplant material is not worked)

20-29:

Large intestine perforation (hole in large intestine)

30-39:

Pain
Mobility decreased (ability to move is reduced)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Abasia (inability to walk)
Anxiety
Emotional distress
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)
Injury
Paronychia (infection in the tissues adjacent to a nail on a finger or toe)

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Rectal haemorrhage (bleeding from anus)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Pyrexia (fever)
Transplant rejection (a transplant material is not worked)
Iron deficiency anaemia
Metrorrhagia (uterine bleeding at irregular intervals)

50-59:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Skin induration (an abnormally hard spot or area on the skin)
Anxiety
Emotional distress
Gait disturbance
Hypertension (high blood pressure)
Injury
Joint contracture (a permanent shortening of a muscle or joint)

60+:

Nocardiosis (an infectious disease affecting either the lungs or whole body)
Pneumonia
Asthenia (weakness)
Deformity (disfigurement)
Depression
Diarrhoea
Dry skin
Emotional distress
Eosinophil count increased
Exfoliative rash (scaly red generalized skin rash)

What are the existing conditions these people have? *

High Blood Pressure: 14 people, 31.11%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 13 people, 28.89%
Immunodeficiency Disorders: 10 people, 22.22%
Pain: 5 people, 11.11%
Diabetes: 5 people, 11.11%
Kidney Transplant Rejection: 4 people, 8.89%
Stable Angina (a constant chest pain): 3 people, 6.67%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 6.67%
Insomnia (sleeplessness): 3 people, 6.67%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fosrenol and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously